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Objectives: To map out-patients with Chronic Obstructive Pulmonary Disease (COPD) with
special reference to patients suffering from acute exacerbations, and to describe COPD health
care structure and process in Swedish clinical practice in a real life setting.
Design: Retrospective, non-interventional, epidemiological survey.
Setting: 141 hospital based out patient clinics (OPC, nZ 30) and primary health care clinics
(PC, nZ 111) were included in the structure evaluation.
Subjects: 1004 COPD diagnosed patients from 100 of the centres (OPC, nZ 26) participated in
the process evaluation.
Methods: All Swedish OPC (nZ 40) and a random sample of 180 PC were asked to answer
a questionnaire regarding COPD care. In addition, data from 10 randomly selected patients
with a documented COPD disease were analysed from the centres.
Results: Spirometers were available at all OPCs and at 99% of the PCs. Spirometry had been
performed in 52% of PC-patients and in 89% of OPC-patients during the last 2 years prior to
the study. More severe patients, as judged by investigator and lung function data, were
treated at OPCs than at PCs. Physiotherapists, occupational therapists and dieticians were
available at >80% of centres. Exacerbation rate was higher at PCs without a specialized nurse,
2.2/year versus 0.9/year at centres with a specialized nurse.6 17 12 06; fax: þ46 46 14 67 93.
l@med.lu.se (C.-G. Lo¨fdahl).
9 Published by Elsevier Ltd.
COPD care in Sweden 405Conclusions: Special attention to COPD, marked by a specialised nurse in primary care
improves the quality, as assessed by a lower number of exacerbations. The structure of COPD
care in Sweden for diagnosed individuals seems satisfactory, but could be improved mainly
through higher availability and educational activities.
ª 2009 Published by Elsevier Ltd.220 letters
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Figure 1 Centres taking part in various parts of the study.
OPC, hospital based outpatient clinic; PC, primary health care
centre.Introduction
During the last two decades a number of national and
international guidelines for treatment of chronic obstruc-
tive pulmonary disease (COPD) have been developed. In the
European Respiratory Society’s recommendations, pub-
lished in 1995, the definitions are descriptive and focused
on the existence of chronic airflow obstruction and the
characterization of COPD as a progressive disease.1 In the
recent international guidelines from 2007, COPD is defined
as ‘‘.a preventable and treatable disease with some
significant extrapulmonary effects.’’.2 It is thus obvious
that the view on COPD has changed during the last decade,
and that COPD now is looked upon with more confidence
and considered to be a disease with systemic engagement.
It is not known how guidelines and recommendations are
used in primary care and, in general, studies of adherence
to guidelines and recommendations are scarce. Recent
studies indicate that the COPD diagnosis is often missed,
both in primary and secondary care.3e5 Thus, there seems
to be a lack of attention with regards to COPD as many
individuals who suffer from COPD are undiagnosed despite
severe disease.3e5
The ‘‘chronic care model’’ (CCM) identifies health care
components such as systems of health care, clinical
information and delivery, as well as self-management and
decision support that encourage high quality care in chronic
diseases.6 This model has been used to improve manage-
ment and prevention of complications in patients with
heart failure and diabetes mellitus, but has not been
extensively implemented in COPD. In a recent systematic
review of CCM in COPD it was demonstrated that applying
two or more components of CCM lowered the risk of
unscheduled visits to emergency rooms and hospital-
isation.7 While instruments aiming at improving care for
patients who suffer from chronic diseases have been
developed, these instruments have only rarely been applied
to patients with COPD. Despite that no efforts are spared to
produce recommendations and guidelines, the interest to
monitor what implications these efforts have in real life is
scarce. In Sweden, the National Board of Health and
Welfare has issued a governing document on how patients
with COPD should be diagnosed, treated and monitored.8
However, no efforts have to day been made to control the
implementation of the guidelines in the health care system.
As the prevalence of COPD is high and increasing9 most
of the patients suffering from this disease are and will be
handled in primary care. In Sweden most primary care
centres have spirometers which constitute an imperative
demand in the diagnosis of COPD. In addition, many
Swedish primary care centres have specialized asthma/
COPD nurses who are responsible for care centres custom-
ized for patients with asthma/COPD. However, the pureexistence of guidelines, equipment for lung function
measurements and access to specialized asthma/COPD
nurse centres do not guarantee high quality care if not
utilized properly.
One aim of the present study was to make a survey of
the structure of the primary and secondary care of patients
with COPD in Sweden, by a questionnaire on handling and
routines of these patients. A further aim was to assess how
monitoring of COPD patients is performed in primary and
secondary care by registration of data from randomly
selected patient records obtained at primary care centres
and hospital based departments/sections of respiratory
diseases.
Methods
Study design
This retrospective, non-interventional, epidemiological
study was designed to describe COPD health care in
Sweden. Participating centres answered a web-based
questionnaire about structure and processes including
nationally agreed10 quality indicators for primary and
Table 2 Asthma/COPD nurses and their training at
primary care centres (nZ 111) in Sweden.
Asthma/COPD nurse present 87%
Nurse time allocated to asthma and
COPD patients
> 0 and> 0.5 hours/week/1000 patients
in the catchment area
31%
0.5e1.5 hours/week/1000 patients in
the catchment area
38%
>1.5 hours/week/1000 patients in
the catchment area
8%
Nurse available but no information
on time allocated
23%
University training of nurses
5 weeks 41%
<5 weeks 25%
No university training 18%
No information on training 16%
Training in spirometry for nurses
1 full day 68%
0.5 days 14%
No spirometry training 5%
No information on spirometry training 13%
406 C.-G. Lo¨fdahl et al.secondary COPD health care (structure evaluation), and
were also asked to answer a separate questionnaire relating
to individual patient’s medical records (process evaluation)
(Fig. 1). All data were collected anonymously and no
monitoring was done at the participating centres. Ethics
Committee approved the study as a Quality Assurance
Project.
Selection of centres
Centres were classified into two groups: hospital based
outpatient clinics (OPCs) and primary health care centres
(PCs). All pulmonary OPCs in Sweden were invited to
participate in the study, of which 30 out of totally 40
accepted the invitation. One hundred and eighty primary
care clinics were randomly selected from a registry of all
primary care clinics in Sweden (OneKey, Pharma Marketing/
Cegedim AB Kista 2004), and stratified into six geographical
regions in proportion to total population of these areas and
size of the PCs. The invited centres comprise approximately
10% of all available PCs in Sweden. Primary care centres
that declined could not be replaced by another centre in
order to keep the original random selection. Out of the 180
contacted PCs, 111 finally accepted to participate in the
study. Thus, in total, health care structure data were
collected from 141 centres (Fig. 1). Included structure and
process data from PCs and OPCs are given in Table 1.
Selection of patient data
Each PC provided data from 10 randomly selected patient
medical records showing a scheduled visit to a physician or
nurse for consultation/treatment for COPD during the
latest 24 months (4 centres reported 11 patients, all
included in the sample) . At the OPCs, data were provided
from the 10 latest medical records with a scheduled visit.
Data collected from patients’ medical records were; year
of birth, sex, recording of body weight, lung function
measurement, classification of COPD (mild, moderate or
severe according to the GOLD guideline classification),
smoking habits and anti-smoking treatment, concomitant
diseases of medical importance, employment status,Table 1 Items evaluated to assess structure quality.
Primary care centres (PC) Hos
- Population in the catchment area - N
- Location of the centre - N
- Number of physicians - C
- Number of patients treated for COPD - C
- Availability of asthma/COPD physician - U
- Availability of asthma/COPD nurse - S
- Training and education of nurse - S
- Usage of spirometer (including calibration routines) - C
- Usage of pulse oxymeter
- Usage of nebulizer
- Smoking cessation program and non-smoking advice
- COPD health care program (local, national)
- COPD rehabilitation program (multidisciplinary
rehabilitation)current COPD therapy, vaccination (influenza and pneu-
mococcal), evaluation of patients quality of life and acute
COPD exacerbations. If the patient had suffered from an
acute exacerbation, information was also collected about
number of COPD related emergency room visits/acute
visits, number of acute exacerbations treated at home, and
number of COPD related hospitalisations. Individual data
were obtained from 1004 patient records.
Statistical analyses
Descriptive statistics were calculated for all variables,
including mean, standard deviation, median, minimum and
maximum values. Total numbers of exacerbations werepital based outpatients clinics (OPC)
umber of physicians
umber of pulmonary specialists
onsulting pulmonary physicians
OPD health care program (local, national)
sage of spirometer (including calibration routines)
moking cessation program and non-smoking advice
pecified training programs (individual or in group)
OPD rehabilitation program (multidisciplinary rehabilitation)
COPD care in Sweden 407calculated by summing number of emergency room visits/
acute visits, number of home treatments and number of
hospitalisation.
Results
Structure of COPD care in primary care
The response rate of the 180 selected PCs was 52% in the
northern part, 65% in the middle part and 93% in the
southern part of Sweden. Of responders, 54% were located
within a town related to a hospital. The average number of
physicians at the PCs was 4.9 (range 1e13) and catchment
area per physician varied from 1856 to 2955 individuals.
During the last two years each primary care physician had,
on average, treated 47 COPD patients and 72% of the
centres had a specially appointed physician who carried
main responsibility for the COPD care.
Almost all (99%) of the participating primary care
centres had spirometers of which 86% were used every
week. At 96% of the PCs a nebuliser for acute treatment
was available and 89% had a pulse oxymeter.
The presence and training of asthma/COPD nurses at PCs
are given in Table 2.
Smoking cessation programs were available at 68% of the
primary care centres and another 10% could refer to such
programmes at adjacent centres or hospitals. At 13% of the
centres, no smoking cessation program was available and
9% referred to smoking cessation by phone. Eighty percent
of the PCs had access to a physiotherapist, 91% to an
occupational therapist and 86% to a dietician, within the
unit, at another primary care centre or at the local
hospital. Regional health care programs were provided inTable 3 Patients characteristics according to medical records
care (OPC, nZ 262). N denotes the number of patients with retr
Prim
N
Age (range) 742
Female (%) 741
FEV1 (% of predicted). Mean (SD) 388
FEV1/VC, pre-bronchodilator. Mean (SD) 372
Reversibility (%) 235
FEV1 (% of predicted) post-bronchodilator. Mean (SD) 239
Proportion of reversible patientsa (%) 235
Current smokers (%) 664
COPD severity (assessed by the doctor)b
Mild (%) 116
Moderate (%) 132
Severe (%) 112
No information (%) 382
Number of exacerbations/year 688
Recording of body weightb (%) 392
Recording of spirometryb (%) 412
Vaccination against influenzab (%) 397
Vaccination against pneumococcib (%) 150
a Reversibility 12% of pre-bronchodilator value.
b According to medical records, during last two years.68% of the PCs and a COPD rehabilitation program was
available in 83% of the OPCs.
Structure of COPD care at hospital based
out-patient clinics (secondary care)
At the 30 participating secondary care units, between 1
and 24 specialists in pulmonary medicine were employed
and almost half of the clinics (nZ 14) used consulting
pulmonary physicians at the time of the study. Spirome-
ters were available at all units and in two thirds of the
clinics a local or a national COPD health care program was
used.
Smoking cessation programmes could be offered at 56%
of the units and in another 40% patients could be referred
to smoking cessation programmes at adjacent clinics within
the hospital or the county. For 43% of the 30 clinics no
information was received on how smoking cessation
programs were organised.
Multidisciplinary rehabilitation of COPD patients was
available at 65% of the clinics, whereas 17% did not have
access to rehabilitation and 18% had to refer patients to
other units in or outside the hospital for rehabilitation.
Physicians, physiotherapists, nurses and dieticians were
involved in multidisciplinary rehabilitation of COPD
patients in approximately 80% of the clinics. The corre-
sponding figures for occupational therapists, almoners and
psychologists were 67%, 70% and 7%, respectively.
Following acute COPD exacerbations 63% of the COPD
patients were followed up at the clinic and 16% were
referred to the primary care for follow up. In 16% of acute
exacerbations no organized follow-up program was
provided.in primary care (PC, nZ 742) and hospital based outpatients
ievable data during the last two years.
ary care (PC) Secondary care (OPC)
Value N Value
70 (42e94) 262 69 (41e91)
54 262 52
58 (19) 234 40 (18)
60 (17) 231 48 (14)
9.4 63 7.6
63 (18) 64 44 (19)
32 63 30
37 250 23
16 18 7
18 33 13
15 133 51
52 78 30
1.04 249 1.48
53 212 81
56 231 88
54 91 35
20 51 19
010
20
30
40
50
60
<30 30-<50 50-<80 ≥80 <30 30-<50 50-<80 ≥80
Hospital OutPatient Clinics Primary Care
%
Figure 2 Percentage of patients in severity groups according
to GOLD in hospital based outpatient clinics (OPCs) centres and
primary health care centres (PCs).
408 C.-G. Lo¨fdahl et al.Individual patient data e comparison between
primary and secondary care
Medical records data revealed differences between
patients treated in primary care and those treated in
hospital based outpatient care (Table 3). Spirometry had
been performed during the last two years in 52% of the
included patients in the primary care and in 89% of the
patients at OPCs. The proportion of severe COPD, as
assessed by the doctor, showed more than half of the
patients to be handled at OPCs (51%) and 15% at the PCs
(Table 3). When GOLD severity classification was used, the
number of more severe patients was evident in the hospital
setting (Table 3, Fig. 2), where the mean FEV1 was 40% of
predicted value as compared to 58% of predicted value in
primary care, both values before bronchodilatation. Patient
characteristics in relation to severity assessed by the doctor
are shown in Table 4.
There was a slight tendency towards classification of the
disease as more severe when judged by the doctor than
when severity was based on lung function tests (pre-bron-
chodilator FEV1) according to GOLD criteria (Table 5).
Employment
Of the patients in working ages (<65 years), 36% were full-
time or part-time gainfully employed. This figure can beTable 4 Patient characteristics grouped by doctors’ reported C
Mild
nZ 134
Moderat
nZ 165
Age (years). Mean (SD) 66 (10) nZ 134 68 (10) n
Pre-bronchodilator FEV1
(% of predicted value).
Mean (SD)
71 (14) nZ 96 54 (15) n
No exacerbations/year.
Mean (SD)
0.58 (0.94) nZ 128 1.10 (1.5
Full/part time employeda (%) 52 nZ 54 46 nZ 6
Smokers (%) 42 nZ 127 38 nZ 1
Ongoing COPD medication
(no of medicines)
2.18 nZ 134 2.94 nZ
a patients below 65 years of age (346 patients).compared to an age matched employment rate in the
general Swedish population, which is approximately 72%.11
For severe disease, 22% of patients were employed and the
corresponding figure for patients with mild disease was 52%
(Table 4).
Exacerbations
Exacerbations were defined as; emergency room visits/
acute visits, number of home treatments with oral corti-
costeroids and/or antibiotics and hospitalisations due to
COPD. Patients treated in hospital based speciality care had
a higher rate of exacerbations than patients treated at
primary care (Table 3). As expected the number of exac-
erbations increased with increasing COPD severity, in mild
COPD exacerbation rate was 0.6/year, whereas in severe
COPD the rate was 2.5/year (Table 4). The number of
exacerbations was correlated with several measures of
structure quality of care.
In primary care the most striking feature was a clear
relation between exacerbations and a specialized nurse to
take care of COPD patients. The mean number of exacer-
bations in PCs with a specialised nurse was 0.9/year,
whereas it was 2.2/year in centres without such a nurse.
This relation was true for all types of exacerbations. There
was also a decreasing rate of exacerbation with increasing
hours of nurse availability (Fig. 3). There was no difference
in COPD severity between centres with or without speci-
alised nurse.
In OPCs there were less exacerbations in specialised
wards (3.11 (SD 4.07) exacerbations/year) than in the
general internal medicine wards (4.78 (SD 6.25) exacerba-
tions/year). This could be explained by a higher prevalence
of more severe patients in generalised wards.
Discussion
In this study, a country wide perspective on the quality of
health care for COPD in Sweden was taken. Sweden is
a country with approximately 9 million inhabitants spread
over a large area, implicating that the health care organi-
sation must depend on good primary care for the most
prevalent diseases. As the Swedish COPD prevalence in the
adult population is about 8%,12 more than half a millionOPD severity.
e Severe
nZ 245
No COPD classification
nZ 460
Z 165 71 (9) nZ 245 71 (10) nZ 460
Z 117 34 (12) nZ 176 55 (19) nZ 233
8) nZ 156 2.52 (3.64) nZ 242 0.88 (1.30) nZ 431
9 22 nZ 63 31 nZ 106
50 25 nZ 224 34 nZ 413
165 4.06 nZ 245 2.70 nZ 460
Table 5 Classification of severity according to GOLD and
judgment in medical record.
Classification according to
medical records
Severity by GOLD (pre-
bronchodilator FEV1)
Mild Moderate Severe Total
<30% of predicted value
(severe)
0 2 75 77
30 to <50% of predicted
value (moderate)
5 44 81 130
50 to <80% of predicted
value (mild)
70 63 20 153
80% of predicted value
(pre-clinical)
21 8 0 29
Total 96 117 176 389
COPD care in Sweden 409adults in Sweden have COPD. The quality of care evaluation
in the study was focused both on the structure and the
process of care.13e17 The most striking finding was that the
frequency of acute exacerbations was lowest in COPD
patient who were controlled in primary care units with
a nurse especially devoted to the care of patients with
asthma and COPD.
The study was performed retrospectively and the health
care centres first answered a questionnaire on the structure
of health care at the centre, and were subsequently asked
to report on the last ten patients handled due to COPD
(OPC) or ten randomly selected patients who had a sched-
uled visit for COPD during the last 24 months (PC). The PCs
were randomly selected from a list of all centres in Sweden.
All hospital centres were asked to participate. The primary
care response rate was 69%, for secondary care units the
response rate was 75%. It could be claimed that there is
a bias towards better structure and process handling among
the responders than among the non-responders. This
suspicion may be supported by the finding that the
possession of spirometers in the primary care centres was
99% in the present study, but approximately 95% in other
recent studies performed in Sweden.18,19 It is, however,
most likely that this bias is small as supported by the finding
that the southern part of Sweden, Ska˚ne, had a 93%0
0.5 
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2
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4
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Figure 3 Mean number of exacerbations in primary care
related to the allocated time for an asthma/COPD nurse. No
info means that the centre has reported that there is a nurse
available, but the time/patient has not been specified.response rate and showed very similar figures as did the rest
of the country in most respects.
With regards to the structure of respiratory care, an
important finding was that the technical equipment was
satisfactory both at the hospital and at the primary care
levels, where 99% of the PCs had spirometers, 96% were
using nebulisers and 89% had pulse oxymeters. However,
the use of spirometers was not as frequent as one would
expect. Only half of the COPD patients had performed
a spirometry during the last two years, whereas lung
function is more often measured in secondary care where
89% of the COPD patients had undergone spirometry during
the last two years. According to the GOLD guidelines the
diagnosis and severity of COPD shall be based on post-
bronchodilator spirometry. In the present study, post-
bronchodilator lung function measurements had only been
performed in 32% of the patients in primary care and in 24%
of the patients in hospital care. As we only registered lung
function measurements during the last two years and most
of the patients already had their diagnosis two years prior
to the study, no firm conclusions could be drawn with
regards to the question whether or not the diagnosis of
COPD was based on post-bronchodilator measurements.
Further, the availability of pulse oxymeters and nebulizers
was high in the various centres, however the frequency of
use of this equipment was not examined.
The staffing at the PCs was satisfactory with 86% of the
centres reporting having specialised nurse for asthma and
COPD patients. This figure is somewhat high and could be an
effect of selection of the primary care units. In an earlier
study in Swedish primary care, only 52% reported having an
asthma nurse at the unit.20 It should however be noted that
the mean time spent per patient was quite short. This
seems to be of importance, as nurse time allocated to COPD
patients had a clear positive influence on exacerbation
rate. Smoking cessation programmes were somewhat less
available, only two thirds of the PCs had an ongoing
programme. It is noteworthy that a clearly structured
smoking cessation programme was missing in more than 40%
of the secondary care units, which was worse than among
PCs where one third lacked a smoking cessation
programme.
The process evaluation revealed a number of interesting
results. The severity of COPD in primary and hospital care is
similar to what would be expected from a Swedish
perspective.18,19 A small proportion of the patients with
severe COPD, according to the classification made by the
physician, were treated in primary care; only 15% of the
COPD patients treated in primary care had severe disease
whereas this figure was about half of the patients in
hospital care. Severe COPD according to GOLD criteria,
which was only possible to assess in a subpopulation of the
patients with FEV1 measurements, was found in 43% of the
patients treated in hospital care and 28% of the primary
care patients.
In GOLD and other guidelines, staging of the disease
according to level of FEV1 is recommended. In the present
study we in addition asked for the clinical evaluation of
severity; where the finding was that clinicians often grade
severity differently than spirometry grading. Even if there
is a correlation for the whole group between clinical and
spirometry grading, it is of interest to note that many other
410 C.-G. Lo¨fdahl et al.factors are built into the clinical evaluation. The ongoing
discussion on this issue, with presentation of scores such as
the BODE-index clearly shows that we need to extend the
grading of severity.21
The data on the number of exacerbations during the last
two years for each patient enabled us to evaluate the
influence of various factors in the management of the
patients. It could be anticipated that the number of exac-
erbations have been important in the clinical evaluation of
severity, which is supported by the fact that in clinically
mild COPD the mean number exacerbations/year was 0.6
whereas it was 2.5 in the severe group. Using exacerbations
as an outcome variable, relating to the burden of disease
both individually and in a society perspective, this study
gives interesting information with regards to the quality of
care. A physician with special interest in COPD at a primary
care centre seems to have a positive effect on exacerbation
rate; 0.95 exacerbations/year when such a doctor is
present and 1.26 exacerbations/year where no physician
with special interest in COPD is present. However the most
influential staff member seems to be the specialised nurse.
In centres without a specialised nurse the exacerbation rate
was more than twice as high as in centres with such a nurse,
something that could not be explained by a difference in
disease severity of the studied COPD patients. A likely
explanation to this is that the easily accessible specialised
nurse may be able to start treatment early and to answer
questions and thereby reduce anxiety. Another reason
might be that the introduction of special knowledge on
different levels has a general impact on the quality of
health care at the institution. The specialised nurse may be
an indicator for a team approach to the COPD patient,
almost always including an interested physician, and
probably also interest from the rest of the staff. Some
studies have tried to evaluate the effect of a specialised
approach with various results.22e24 In a randomised trial,
nurse-assisted home care did not significantly change
health status and there was no effect on acute event, most
likely due to very low frequency of events.22 In another
study, education and training of patients reduced the
number of emergency visits, which also were correlated to
health status.23 According to a recent Australian study,
a trained nurse performing spirometries improves the
diagnostic procedure in COPD patients.24
In hospital based outpatient care the number of exac-
erbations is, as expected, higher than in primary care. One
obvious reason, as also evident in our data, is that the
severity of disease differs between primary and secondary
care patients. However, even when adjusting for the
doctor-reported severity, the difference remains signifi-
cant. The influence of a specialised nurse in primary care
certainly has an influence. In this study we also noticed that
the exacerbation frequency was somewhat higher in
patients treated in general internal medicine that in those
treated in specialised pulmonary departments (data not
presented). Differences in the co-morbidity spectrum are
a probable explanatory factor, but differences in the
quality of care can not be excluded.
An issue of importance when evaluating the COPD care
from a nationwide perspective is under diagnosis as well as
other diagnostic mistakes, e g that patients receive a COPD
diagnosis without any airway obstruction (e.g. patients withchronic bronchitis). The process part of this study only
evaluates care in diagnosed cases of COPD. The problem of
under diagnosis, most pronounced in mild disease, has been
emphasised in a Swedish epidemiological study.25 The issue
of misdiagnosis has not been possible to evaluate in this
study, even if it certainly is an aspect of the quality of care.
In conclusion, this study shows that the structural
development of COPD care in Sweden is satisfactory, but
treatment is not optimal at all management levels.
A special focus on COPD care manifested by specialized
COPD nurses at primary care centres improved the status of
the disease as assessed by a decrease in the number of
exacerbations. As exacerbations is a major driver of costs in
COPD, access to specialized COPD nurses will most likely
influence the society burden of the disease.
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